Why is $ANIP moving today? · SEC 8-K archive

$ANIP SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $ANIP: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $ANIP filing catalyst

Why did $ANIP trigger an AI stock catalyst alert?

$ANIP triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: ANI Pharmaceuticals Reports Strong Q3 Growth, Raises Lower End of FY Guidance. Key points: - Q3 net revenue increased 27.6% YoY to $290.8M; Purified Cortrophin Gel rose 36.1% to $138.7M. - GAAP diluted EPS reached $1.51 with GAAP net income of $35.1M and adj. EBITDA of $83.3M (+39.8% YoY). - FY Adjusted Non-GAAP EPS guidance raised to $9.37-$9.71 (prior: $9.19-$9.69).

How did $ANIP stock react after the SEC filing?

After the SEC 8-K for $ANIP, observed market reaction: T0 price $71.65. Past moves do not guarantee future results.

Where can I get real-time $ANIP SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $ANIP via Telegram and the VIP Web Terminal from €10/month.

$ANIP

$ANIP – ANI Pharmaceuticals Reports Strong Q3 Growth, Raises Lower End of FY Guidance

ANI PHARMACEUTICALS INC

2026-11-05 00:00:00 UTC · SEC 8-K · All $ANIP

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.5 / 10)

Q3 net revenue increased 27.6% YoY to $290.8M; Purified Cortrophin Gel rose 36.1% to $138.7M.
GAAP diluted EPS reached $1.51 with GAAP net income of $35.1M and adj. EBITDA of $83.3M (+39.8% YoY).
FY Adjusted Non-GAAP EPS guidance raised to $9.37-$9.71 (prior: $9.19-$9.69).

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →